While Alimentation Couche-Tard shareholders have enjoyed solid total returns over five years, a closer look reveals a growing disconnect between its stock performance and underlying profit growth, with recent underperformance adding to investor uncertainty.
Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.
A routine commute in Minneapolis turns into a biometric checkpoint, spotlighting the advanced surveillance tools—from facial recognition apps to vast data networks—now central to federal immigration enforcement. As operations intensify, questions mount over privacy, oversight, and the line between targeted enforcement and dragnet surveillance.
Russian forces are integrating Starlink satellite terminals into their drone fleet, creating a new generation of long-range, jamming-resistant weapons capable of striking deep behind Ukrainian lines and into NATO territory, according to intelligence reports and military analysts.
A U.S. Navy destroyer has docked at Israel's southern port of Eilat, a move reported by Israeli media as U.S.-Iranian tensions simmer. While officials describe the deployment as routine, it coincides with a significant American military buildup in the region.
A provocative art installation in Tokyo, featuring a violently thrashing robot dog restrained by a metal chain, is drawing crowds and forcing viewers to confront uneasy questions about the future of artificial intelligence, ethics, and our emotional connection to machines.
A deep dive into Kadant Inc.'s intrinsic value using a Discounted Cash Flow model suggests the stock is trading near its estimated fair value of $273, raising questions about its near-term upside potential amid current market prices.
Starbucks is overhauling its popular Rewards program for over 35 million U.S. members, introducing a tiered structure (Green, Gold, Reserve) designed to offer faster, more personalized benefits and deeper integration with travel partners.
Multiple executives and board members at AmeriServ Financial have been buying shares in the company over the past year, a move often interpreted as a bullish signal for the regional bank's prospects.
A recent 13% quarterly gain offers little solace for long-term shareholders of America's Car-Mart, as the used vehicle retailer's stock remains down 80% over five years amid profitability challenges and revenue growth concerns.
Amidst market turbulence, European investors are turning to high-yield dividend stocks for income stability. We examine three companies offering compelling payouts, weighing their potential rewards against inherent risks.
Shares of life sciences toolmaker Qiagen (NYSE:QGEN) have shown renewed momentum, gaining over 12% in the past month. This surge brings the company's valuation into sharp focus, with analysts divided between near-term earnings multiples and long-term cash flow projections.
Uber Technologies is aggressively expanding its autonomous vehicle ecosystem through new partnerships and its AV Labs division, even as a landmark New Jersey court decision threatens to upend its core gig-economy labor model, setting the stage for a pivotal clash between its future vision and present-day regulatory challenges.
Linde plc (LIN) shares have shown consistent upward momentum, closing recently at $455. While short-term performance is strong, a deeper valuation analysis reveals a complex picture, with divergent views on whether the stock is a bargain or fully priced.
Nomura Holdings (TSE:9716) has surged 33% in three months, briefly pausing last week. As shares hover around ¥1,367, analysts debate whether the market has fully priced in the brokerage's recovery or if a significant valuation gap remains.
Elevra Lithium (ASX:ELV) shares have tumbled over 30% in a week, abruptly reversing a stellar year-long rally. With no clear catalyst, investors are left weighing whether the pullback presents a buying window or signals deeper concerns in the lithium sector.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
Tencent Holdings has received regulatory approval to import Nvidia's advanced H200 AI chips, a significant move that enhances its competitive edge in cloud and AI services while navigating ongoing US technology restrictions.
Wall Street analysts have issued a dramatic upgrade to revenue projections for Americas Gold and Silver Corp., forecasting a surge to $383 million by 2026 and signaling accelerated growth far beyond industry peers.
Federal officials have issued provisional approval to relocate 30 beluga whales and four dolphins from the shuttered Ontario park to accredited U.S. aquariums, averting an immediate euthanasia threat pending final health and care plans.
